tiprankstipranks
Trending News
More News >
Oryzon Genomics SA (DE:ORN)
FRANKFURT:ORN
Germany Market

Oryzon Genomics SA (ORN) Income Statement

Compare
1 Followers

Oryzon Genomics SA Income Statement

Last quarter (Q2 2025), Oryzon Genomics SA's total revenue was €0.00, a decrease of -100.00% from the same quarter last year. In Q2, Oryzon Genomics SA's net income was €103.34K. See Oryzon Genomics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 0.00€ 7.36M€ 0.00€ 0.00€ 10.62M
Gross Profit
€ -133.91K€ 7.06M€ 13.95M€ 15.23M€ 9.87M
Operating Expenses
€ 6.29M€ 11.48M€ 18.50M€ 20.72M€ 16.88M
Depreciation and Amortization
€ 133.91K€ 147.75K€ 130.13K€ 146.59K€ 144.33K
EBITDA
€ -6.29M€ -4.43M€ -4.43M€ -5.35M€ -6.88M
Operating Income
€ -6.42M€ -4.42M€ -4.55M€ -5.49M€ -7.01M
Other Income/Expenses
€ 820.43K€ -1.15M€ -1.55M€ -1.07M€ -169.00K
Pretax Income
€ -5.60M€ -5.57M€ -6.10M€ -6.56M€ -7.18M
Net Income
€ -2.61M€ -3.67M€ -3.35M€ -4.23M€ -4.69M
Per Share Metrics
Basic EPS
€ -0.04€ -0.06€ -0.06€ -0.08€ -0.09
Diluted EPS
€ -0.04€ -0.06€ -0.06€ -0.08€ -0.09
Weighted Average Shares Outstanding
74.37M 64.37M 60.88M 56.04M 52.76M
Weighted Average Shares Outstanding (Diluted)
74.37M 64.37M 60.88M 56.04M 52.76M
Currency in EUR

Oryzon Genomics SA Earnings and Revenue History